Callan JMB (CJMB): Utang-utang marang kapitalisasi buku

Callan JMB Inc (CJMB) is actively implementing high-precision tools for robotic surgery and orthopedics. The current debt-to-equity ratio on the GURU.Markets chart demonstrates local dynamics, where the current mark equals 3.15. A focus on surgical centers and rising healthcare spending supports the business, while management's expertise in system maintenance ensures stable customer loyalty.

CJMB (Callan JMB) riwayat Utang marang nilai buku saka 06.02.2025 nganti 27.10.2026

This indicator determines the degree of financial leverage by comparing total liabilities to the book value of equity. This ratio allows an investor to assess leverage risk and the efficiency of the financing structure. By analyzing changes in the proportion of total debt to book capitalization, one can track the dynamics of the debt load. For Callan JMB Inc (CJMB), this balance is critical when forming inventory reserves for components. Debt optimization provides the resources necessary to diversify supply chains for medical optics.

Karo sapa Callan JMB Inc saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku NXGL (NEXGEL)|RVP - Utang-utang marang aset resik|HBIO (Harvard Bioscience, Inc.) - Utang-utang marang kapitalisasi buku|Femasys Corporation (FEMY) - Utang marang nilai buku|MHUA (Meihua Medical Technologies) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku POAI|Rasio utang marang kapitalisasi buku Atrion (ATRI)|Rasio utang marang kapitalisasi buku NURO (NeuroMetrix Inc)